Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Cell Rep ; 22(7): 1861-1874, 2018 02 13.
Article in English | MEDLINE | ID: mdl-29444437

ABSTRACT

The maintenance of eukaryotic genome stability is ensured by the interplay of transcriptional as well as post-transcriptional mechanisms that control recombination of repeat regions and the expression and mobility of transposable elements. We report here that mutations in two (cytosine-5) RNA methyltransferases, Dnmt2 and NSun2, impact the accumulation of mobile element-derived sequences and DNA repeat integrity in Drosophila. Loss of Dnmt2 function caused moderate effects under standard conditions, while heat shock exacerbated these effects. In contrast, NSun2 function affected mobile element expression and genome integrity in a heat shock-independent fashion. Reduced tRNA stability in both RCMT mutants indicated that tRNA-dependent processes affected mobile element expression and DNA repeat stability. Importantly, further experiments indicated that complex formation with RNA could also contribute to the impact of RCMT function on gene expression control. These results thus uncover a link between tRNA modification enzymes, the expression of repeat DNA, and genomic integrity.


Subject(s)
DNA (Cytosine-5-)-Methyltransferases/genetics , Drosophila Proteins/genetics , Drosophila melanogaster/enzymology , Drosophila melanogaster/genetics , Gene Expression Regulation , Genomic Instability , Interspersed Repetitive Sequences/genetics , Amino Acid Sequence , Animals , Base Sequence , Biocatalysis , DNA (Cytosine-5-)-Methyltransferases/chemistry , DNA (Cytosine-5-)-Methyltransferases/metabolism , DNA Methylation/genetics , DNA Transposable Elements/genetics , Drosophila Proteins/chemistry , Drosophila Proteins/metabolism , Female , Gene Silencing , Genetic Loci , Heat-Shock Response/genetics , Male , RNA Stability , RNA, Transfer/genetics , Transcriptome/genetics , Y Chromosome/genetics
2.
Nat Commun ; 8: 15373, 2017 05 12.
Article in English | MEDLINE | ID: mdl-28497796

ABSTRACT

Interleukin-2 (IL-2) is an established therapeutic agent used for cancer immunotherapy. Since treatment efficacy is mediated by CD8+ and NK cell activity at the tumour site, considerable efforts have focused on generating variants that expand these subsets systemically, as exemplified by IL-2/antibody complexes and 'superkines'. Here we describe a novel determinant of antitumour activity using fusion proteins consisting of IL-2 and the antibody fragment crystallizable (Fc) region. Generation of long-lived IL-2-Fc variants in which CD25 binding is abolished through mutation effectively prevents unwanted activation of CD25+ regulatory T-cells (Tregs) and results in strong expansion of CD25- cytotoxic subsets. Surprisingly, however, such variants are less effective than wild-type IL-2-Fc in mediating tumour rejection. Instead, we report that efficacy is crucially dependent on depletion of Tregs through Fc-mediated immune effector functions. Our results underpin an unexpected mechanism of action and provide important guidance for the development of next generation IL-2 therapeutics.


Subject(s)
Antineoplastic Agents/pharmacology , Immunoglobulin Fragments/immunology , Immunotherapy , Lymphocyte Activation , Neoplasms/immunology , T-Lymphocytes, Regulatory/immunology , Animals , Antibodies, Monoclonal/immunology , CD8-Positive T-Lymphocytes/immunology , Cytokines/metabolism , Female , Immunoglobulin G/immunology , Immunologic Memory , Interleukin-2/pharmacology , Interleukin-2 Receptor alpha Subunit/metabolism , Killer Cells, Natural/immunology , Leukocytes, Mononuclear/cytology , Lymphocyte Subsets/immunology , Melanoma, Experimental , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mutagenesis , Neoplasms/therapy , Recombinant Proteins/metabolism , Spleen/cytology , Spleen/metabolism
3.
Int J Mass Spectrom ; 307(1-3): 105-111, 2011 Oct 01.
Article in English | MEDLINE | ID: mdl-22723737

ABSTRACT

A high throughput method based on flow injection analysis was developed and validated for the quantification of the peptide Bß(15-42) in cellular samples comparing different labeling strategies and detection methods. The used labels were 1,4,7,10-tetraazacyclododecane-N, N', N'', N'''-tetraaceticacid (In-DOTA) and 2-(4-isothiocyanatobenzyl) - 1,4,7,10-tetraazacyclododecane-N, N', N'', N'''-tetraacetic acid (In-DOTA-Bn) for elemental labeling. 6-Hydroxy-9-(2-carboxyphenyl)- (3H)-xanthen-3-on (fluorescein) was employed as fluorescence label. The explored peptide (mass = 3 kD) is a novel candidate drug, which shows an anti-inflammatory effect after an event of myocardial infarction. The analysed samples were fractioned cell compartments of human umbilical cord vein endothelial cells (HUVEC) maintained via lysis with Triton X buffer. In order to enhance sensitivity and selectivity of peptide quantification via flow injection the peptide was labeled prior to incubation using elemental and fluorescence labels. Quantification of the elemental and fluorescence labeled peptide was performed via flow injection analysis combined with inductive coupled plasma sector field mass spectrometry (FIA-ICP-SFMS) or fluorescence detection (FIA-FLD), respectively. The employed quantification strategies were external calibration in the case of fluorescence detection and external calibration with and without internal standardization and on-line IDMS in the case of ICP-MS detectionThe limit of detection (LOD) for FIA-ICP-MS was 9 pM In-DOTA-Bß(15-42) (0.05 fmol absolute) whereas FIA-FLD showed a LOD of 100 pM (3 fmol absolute) for the fluorescein labeled peptide. Short term precision of FIA-ICP-MS was superior for all ICP-MS based quantification strategies compared to FIA-FLD (FIA-ICP-SFMS: 0.3-3.3%; FIA-FLD: 6.5%). Concerning long term precision FIA-ICP-SFMS with on-line IDMS and internal standardization showed the best results (3.1 and 4.6%, respectively) whereas the external calibration of both applied methodological approaches was only in the range of 10 %.The concentrations in the Triton X soluble fraction relative to the applied amount of Indium in the cell culture were in the range of 0.75-1.8% for In-DOTA or 0.30-0.79% for the 2-(4-isothiocyanatobenzyl) - 1,4,7,10-tetraazacyclododecane-N, N', N'', N'''-tetraacetic acid (In-DOTA-Bn) labeled peptide Bß(15-42). In the Triton X insoluble fraction the relative concentrations of Indium were 0.03-0.18% for the In-DOTA labeled peptide and 0.03-0.13% for Bß(15-42)-In-DOTA-Bn.

4.
PLoS One ; 4(4): e5391, 2009.
Article in English | MEDLINE | ID: mdl-19401765

ABSTRACT

Loss of vascular barrier function causes leak of fluid and proteins into tissues, extensive leak leads to shock and death. Barriers are largely formed by endothelial cell-cell contacts built up by VE-cadherin and are under the control of RhoGTPases. Here we show that a natural plasmin digest product of fibrin, peptide Bbeta15-42 (also called FX06), significantly reduces vascular leak and mortality in animal models for Dengue shock syndrome. The ability of Bbeta15-42 to preserve endothelial barriers is confirmed in rats i.v.-injected with LPS. In endothelial cells, Bbeta15-42 prevents thrombin-induced stress fiber formation, myosin light chain phosphorylation and RhoA activation. The molecular key for the protective effect of Bbeta15-42 is the src kinase Fyn, which associates with VE-cadherin-containing junctions. Following exposure to Bbeta15-42 Fyn dissociates from VE-cadherin and associates with p190RhoGAP, a known antagonists of RhoA activation. The role of Fyn in transducing effects of Bbeta15-42 is confirmed in Fyn(-/-) mice, where the peptide is unable to reduce LPS-induced lung edema, whereas in wild type littermates the peptide significantly reduces leak. Our results demonstrate a novel function for Bbeta15-42. Formerly mainly considered as a degradation product occurring after fibrin inactivation, it has now to be considered as a signaling molecule. It stabilizes endothelial barriers and thus could be an attractive adjuvant in the treatment of shock.


Subject(s)
Endothelium, Vascular/drug effects , Endothelium, Vascular/physiopathology , Fibrin Fibrinogen Degradation Products/pharmacology , Peptide Fragments/pharmacology , Severe Dengue/drug therapy , Severe Dengue/physiopathology , Amino Acid Sequence , Animals , Antigens, CD/metabolism , Cadherins/metabolism , Capillaries/drug effects , Capillaries/physiopathology , Disease Models, Animal , Fibrin Fibrinogen Degradation Products/chemistry , Focal Adhesion Kinase 1/metabolism , Humans , Lipopolysaccharides/toxicity , Male , Mice , Mice, Inbred BALB C , Mice, Knockout , Molecular Sequence Data , Peptide Fragments/chemistry , Pneumonia/etiology , Pneumonia/physiopathology , Proto-Oncogene Proteins c-fyn/deficiency , Proto-Oncogene Proteins c-fyn/genetics , Proto-Oncogene Proteins c-fyn/physiology , Rats , Rats, Sprague-Dawley , Stress Fibers/drug effects , Stress Fibers/physiology , Thrombin/pharmacology , rho GTP-Binding Proteins/metabolism , rhoA GTP-Binding Protein
5.
BMC Microbiol ; 8: 188, 2008 Oct 30.
Article in English | MEDLINE | ID: mdl-18973658

ABSTRACT

BACKGROUND: The luxS/AI-2 signaling pathway has been reported to interfere with important physiological and pathogenic functions in a variety of bacteria. In the present study, we investigated the functional role of the streptococcal luxS/AI-2 system in metabolism and diverse aspects of pathogenicity including the adaptation of the organism to stress conditions using two serotypes of Streptococcus pyogenes, M1 and M19. RESULTS: Exposing wild-type and isogenic luxS-deficient strains to sulfur-limited media suggested a limited role for luxS in streptococcal activated methyl cycle metabolism. Interestingly, loss of luxS led to an increased acid tolerance in both serotypes. Accordingly, luxS expression and AI-2 production were reduced at lower pH, thus linking the luxS/AI-2 system to stress adaptation in S. pyogenes. luxS expression and AI-2 production also decreased when cells were grown in RPMI medium supplemented with 10% serum, considered to be a host environment-mimicking medium. Furthermore, interaction analysis with epithelial cells and macrophages showed a clear advantage of the luxS-deficient mutants to be internalized and survive intracellularly in the host cells compared to the wild-type parents. In addition, our data revealed that luxS influences the expression of two virulence-associated factors, the fasX regulatory RNA and the virulence gene sibA (psp). CONCLUSION: Here, we suggest that the group A streptococcal luxS/AI-2 system is not only involved in the regulation of virulence factor expression but in addition low level of luxS expression seems to provide an advantage for bacterial survival in conditions that can be encountered during infections.


Subject(s)
Adaptation, Physiological , Bacterial Proteins/metabolism , Carbon-Sulfur Lyases/metabolism , Homoserine/analogs & derivatives , Lactones/metabolism , Signal Transduction , Streptococcus pyogenes/physiology , Acids/pharmacology , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/biosynthesis , Bacterial Proteins/genetics , Base Sequence , Carbon-Sulfur Lyases/genetics , Epithelial Cells/microbiology , Gene Deletion , Homoserine/metabolism , Hydrogen-Ion Concentration , Macrophages/microbiology , Microbial Viability , Molecular Sequence Data , Streptococcus pyogenes/genetics , Transcription Initiation Site , Virulence Factors/biosynthesis
SELECTION OF CITATIONS
SEARCH DETAIL
...